Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127811571 | 12781157 | 1 | I | 20110815 | 20160914 | 20160926 | 20160926 | EXP | US-TEVA-695624USA | TEVA | 83.00 | YR | F | Y | 49.03000 | KG | 20160926 | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127811571 | 12781157 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MILLIGRAM DAILY; | D | 18413 | 40 | MG | QD | ||||||
| 127811571 | 12781157 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | D | 18413 | 40 | MG | |||||||||
| 127811571 | 12781157 | 3 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 600 MILLIGRAM DAILY; | 0 | 200 | MG | TABLET | TID | ||||||
| 127811571 | 12781157 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 127811571 | 12781157 | 5 | C | LOTREL | AMLODIPINE BESYLATEBENAZEPRIL HYDROCHLORIDE | 1 | 10/20 MG | 0 | QD | ||||||||||
| 127811571 | 12781157 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | ||||||||
| 127811571 | 12781157 | 7 | C | RISEDRONATE | RISEDRONATE SODIUM | 1 | 5 MILLIGRAM DAILY; | 0 | 35 | MG | /wk | ||||||||
| 127811571 | 12781157 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 81 MILLIGRAM DAILY; | 0 | 81 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127811571 | 12781157 | 1 | Hypertension |
| 127811571 | 12781157 | 3 | Osteoarthritis |
| 127811571 | 12781157 | 4 | Gastric disorder |
| 127811571 | 12781157 | 5 | Hypertension |
| 127811571 | 12781157 | 6 | Hyperlipidaemia |
| 127811571 | 12781157 | 7 | Osteoporosis |
| 127811571 | 12781157 | 8 | Cardiovascular event prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127811571 | 12781157 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127811571 | 12781157 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127811571 | 12781157 | 1 | 20110624 | 0 | ||
| 127811571 | 12781157 | 3 | 20100224 | 20110624 | 0 | |
| 127811571 | 12781157 | 4 | 20100224 | 20110624 | 0 | |
| 127811571 | 12781157 | 5 | 1995 | 0 | ||
| 127811571 | 12781157 | 6 | 2005 | 0 | ||
| 127811571 | 12781157 | 7 | 1998 | 0 | ||
| 127811571 | 12781157 | 8 | 1990 | 0 |